What should you know about metastatic TNBC outlook?

Metastatic means that breast cancer cells have spread beyond the breast and nearby lymph nodes to another part of the body. Triple-negative describes cancer cells that do not have oestrogen or progesterone receptors and do not make excess HER2 protein, so hormone treatment and standard HER2-targeted treatment are not the usual options. The outlook is shaped by where the cancer has spread, how extensive it is, how quickly it changes, the tumour's test results, previous treatment, and how well the person can receive treatment.

Published figures describe groups of people treated in the past; they cannot account for every newer medicine, tumour feature, or personal circumstance. Your oncology team can explain what the available information means for your situation and may discuss goals such as shrinking cancer, easing symptoms, slowing growth, and preserving daily function.

Ask whether the biopsy has been reviewed for receptor status and other markers that could affect treatment. Discuss the purpose of each proposed option, how response will be checked, and which side effects should be reported promptly. Depending on the tumour's findings and your previous treatment, your team may discuss chemotherapy, immunotherapy, or PARP inhibitor therapy. Supportive care can be added at any stage to manage pain, nausea, breathlessness, fatigue, sleep, mood, and practical needs; it does not mean that cancer treatment has stopped.

Keep a record of symptoms, medicines, appointments, and questions. If possible, bring someone to consultations or ask for a written treatment plan. A second oncology opinion can help when you want another view of the diagnosis or choices.

Contact your cancer team promptly about a new or worsening symptom, fever, repeated vomiting, inability to drink, uncontrolled pain, new confusion, or marked weakness. Seek urgent help for severe breathlessness, chest pain, sudden weakness on one side, a seizure, or difficulty staying awake. Follow the emergency instructions from your treatment centre, especially if you are receiving medicines that can affect infection risk or blood counts.

Which parts of my diagnosis most influence my outlook? What is the aim of the recommended treatment? How will we know whether it is helping? Are there marker tests or clinical options relevant to me? Which symptoms should lead me to call the team the same day?